CAMBRIDGE, Mass. (AP) _ LogicBio Therapeutics Inc. (LOGC) on Monday reported a loss of $7.1 million in its fourth quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 41 cents.
For the year, the company reported a loss of $17.6 million, or $3.04 per share.
LogicBio Therapeutics shares have fallen 5 percent since the beginning of the year.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LOGC at https://www.zacks.com/ap/LOGC